Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED) AZ201801

A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AZR-MD-001 in Patients with Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED)

Register Today!

Start DateJanuary 2022
End DateSeptember 2022
Trial Duration1 year
Number of Visits7
Lead CRCAndrea Carruthers
StatusOngoing

For additional information
on this trial contact:

Phone705-566-0005